From: Lessons learned from hemolytic uremic syndrome registries: recommendations for implementation
Reg.3 [40] | |||||||
---|---|---|---|---|---|---|---|
Geographical coverage | Regional | ✓ | – | – | – | – | – |
National | – | – | ✓ | ✓ | – | ✓ | |
International | – | ✓ | – | – | ✓ | – | |
Purposes | Clinical | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
Research-based | ✓ | ✓ | ✓ | – | ✓ | ✓ | |
Epidemiological-based | – | – | – | ✓ | ✓ | ✓ | |
Data set | Demographics | ✓ | ✓ | – | ✓ | ✓ | ✓ |
Clinical history | ✓ | ✓ | – | ✓ | ✓ | ✓ | |
Paraclinical measures | ✓ | ✓ | – | ✓ | ✓ | ✓ | |
Treatment | ✓ | ✓ | – | ✓ | ✓ | ✓ | |
Outcomes | ✓ | ✓ | – | ✓ | ✓ | ✓ | |
Biological samples | – | ✓ | – | – | ✓ | – | |
Patient evaluation (safety/drug efficacy) | – | – | – | – | – | – | |
Data quality assessment strategy | Completion of data | ✓ | – | – | – | – | – |
Physician’s participation in data quality control | – | – | – | – | – | – | |
Following data quality guidelines | – | – | – | – | – | ✓ | |
Using of data quality indicators | – | – | – | – | – | – | |
Evaluating and auditing data quality | – | – | – | ✓ | – | ✓ | |
Training courses on data quality | – | – | – | – | – | ✓ | |
Data errors tracking | – | – | – | ✓ | – | – | |
Real-time evaluation of data at the time of its entry | – | – | – | – | – | – | |
Inclusion criteria | Atypical HUS | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
Typical UHS | – | – | – | ✓ | – | – | |
Children | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
All ages | ✓ | ✓ | ✓ | ✓ | – | ✓ | |
Exclusion criteria | Atypical HUS | – | – | – | * | – | – |
Typical UHS | ✓ | – | ✓ | – | – | – | |
Adults | – | – | – | – | ✓ | – | |
Registrars | Physicians (nephrologists) | ✓ | – | ✓ | – | ✓ | ✓ |
Data collection | Retrospective | ✓ | ✓ | – | ✓ | – | – |
Prospective | ✓ | ✓ | ✓ | ✓ | ✓ | – | |
Data sources | Healthcare centers | ✓ | ✓ | –** | ✓ | ✓ | ✓ |
Diagnostic centers | – | – | ✓ | ✓ | – | – | |
Research centers | – | – | – | – | ✓ | ✓ |
Total | ||||||
---|---|---|---|---|---|---|
Geographical coverage | Regional | – | – | – | – | 1 |
National | – | – | ✓ | ✓ | 5 | |
International | ✓ | ✓ | – | – | 4 | |
Purposes | Clinical | ✓ | ✓ | ✓ | ✓ | 9 |
Research-based | – | ✓ | ✓ | ✓ | 8 | |
Epidemiological-based | ✓ | – | – | ✓ | 5 | |
Data set | Demographics | ✓ | ✓ | ✓ | ✓ | 9 |
Clinical history | ✓ | ✓ | ✓ | ✓ | 9 | |
Paraclinical measures | ✓ | ✓ | ✓ | ✓ | 9 | |
Treatment | ✓ | ✓ | ✓ | ✓ | 9 | |
Outcomes | ✓ | ✓ | ✓ | ✓ | 9 | |
Biological samples | – | – | – | ✓ | 4 | |
Patient evaluation (safety/drug efficacy) | – | ✓ | – | – | 1 | |
Data quality assessment strategy | Completion of data | – | – | – | – | 1 |
Physician’s participation in data quality control | – | ✓ | ✓ | – | 2 | |
Following data quality guidelines | – | – | – | – | 1 | |
Using of data quality indicators | – | – | – | ✓ | 1 | |
Evaluating and auditing data quality | – | – | – | – | 2 | |
Training courses on data quality | – | – | – | – | 1 | |
Data errors tracking | – | – | – | – | 1 | |
Real-time evaluation of data at the time of its entry | – | – | – | ✓ | 1 | |
Inclusion criteria | Atypical HUS | – | ✓ | ✓ | – | 8 |
Typical UHS | ✓ | – | – | – | 2 | |
Children | ✓ | ✓ | ✓ | – | 9 | |
All ages | ✓ | ✓ | – | – | 7 | |
Exclusion criteria | Atypical HUS | * | – | – | – | 2 |
Typical UHS | – | ✓ | – | – | 3 | |
Adults | – | – | ✓ | – | 2 | |
Registrars | Physicians (nephrologists) | ✓ | ✓ | ✓ | ✓ | 8 |
Data collection | Retrospective | ✓ | – | ✓ | – | 5 |
Prospective | – | ✓ | ✓ | ✓ | 8 | |
Data sources | Healthcare centers | ✓ | ✓ | ✓ | ✓ | 9 |
Diagnostic centers | – | – | – | – | 2 | |
Research centers | – | – | – | – | 2 |